KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Co-Diagnostics (CODX) Other financing activities (2017 - 2020)

Historic Other financing activities for Co-Diagnostics (CODX) over the last 3 years, with Q4 2020 value amounting to -$1.0.

  • Co-Diagnostics' Other financing activities changed N/A to -$1.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $1.5 million, marking a year-over-year increase of 14595.3%. This contributed to the annual value of $1.5 million for FY2020, which is 14595.3% up from last year.
  • Per Co-Diagnostics' latest filing, its Other financing activities stood at -$1.0 for Q4 2020.
  • Co-Diagnostics' Other financing activities' 5-year high stood at $1.5 million during Q1 2020, with a 5-year trough of -$1.0 in Q4 2020.
  • In the last 3 years, Co-Diagnostics' Other financing activities had a median value of $800389.0 in 2017 and averaged $764674.8.
  • Data for Co-Diagnostics' Other financing activities shows a peak YoY increase of 14595.32% (in 2020) and a maximum YoY decrease of 14595.32% (in 2020) over the last 5 years.
  • Quarter analysis of 3 years shows Co-Diagnostics' Other financing activities stood at $1.0 million in 2017, then crashed by 41.19% to $592764.0 in 2019, then tumbled by 100.0% to -$1.0 in 2020.
  • Its Other financing activities was -$1.0 in Q4 2020, compared to $1.5 million in Q1 2020 and $592764.0 in Q1 2019.